-+ 0.00%
-+ 0.00%
-+ 0.00%

Kanghong Pharmaceutical (002773.SZ) obtained the drug registration certificate for briprazole tablets

Zhitongcaijing·12/25/2025 11:17:01
Listen to the news

Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. The company recently received the “Drug Registration Certificate” (certificate numbers: 2025S03922, 2025S03923) for bryprazole tablets issued by the State Drug Administration and approved the registration. The mechanism of action of brypiprazole for the treatment of schizophrenia is unclear. It may be mediated by a combination of serotonin 5-HT1A and dopamine D2 receptor agonist activity and serotonin 5-HT2A receptor antagonist activity.